Correction: Zanubrutinib: past, present, and future

Constantine S. Tam; Javier L. Muñoz; John F. Seymour; Stephen Opat

doi:10.1038/s41408-023-00926-3

Correction: Zanubrutinib: past, present, and future

Constantine S. Tam, Javier L. Muñoz, John F. Seymour, Stephen Opat

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Abstract

In the sentence beginning ‘Zanubrutinib achieved 100% peripheral blood...’ in this article, the text ‘160 mg twice daily (BID) or 320 mg once daily (QD), respectively’ should have read ‘320 mg once daily (QD) or 160 mg twice daily (BID), respectively.’.

Original language	English
Pages (from-to)	154
Number of pages	1
Journal	Blood Cancer Journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41408-023-00926-3
Publication status	Published - 2 Oct 2023

Access to Document

10.1038/s41408-023-00926-3Licence: CC BY

Cite this

@article{6f12ec68d74a494cbf445effe5eba60d,

title = "Correction: Zanubrutinib: past, present, and future ",

abstract = "In the sentence beginning {\textquoteleft}Zanubrutinib achieved 100% peripheral blood...{\textquoteright} in this article, the text {\textquoteleft}160 mg twice daily (BID) or 320 mg once daily (QD), respectively{\textquoteright} should have read {\textquoteleft}320 mg once daily (QD) or 160 mg twice daily (BID), respectively.{\textquoteright}.",

author = "Tam, {Constantine S.} and Mu{\~n}oz, {Javier L.} and Seymour, {John F.} and Stephen Opat",

year = "2023",

month = oct,

day = "2",

doi = "10.1038/s41408-023-00926-3",

language = "English",

volume = "13",

pages = "154",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Zanubrutinib: past, present, and future

AU - Tam, Constantine S.

AU - Muñoz, Javier L.

AU - Seymour, John F.

AU - Opat, Stephen

PY - 2023/10/2

Y1 - 2023/10/2

N2 - In the sentence beginning ‘Zanubrutinib achieved 100% peripheral blood...’ in this article, the text ‘160 mg twice daily (BID) or 320 mg once daily (QD), respectively’ should have read ‘320 mg once daily (QD) or 160 mg twice daily (BID), respectively.’.

AB - In the sentence beginning ‘Zanubrutinib achieved 100% peripheral blood...’ in this article, the text ‘160 mg twice daily (BID) or 320 mg once daily (QD), respectively’ should have read ‘320 mg once daily (QD) or 160 mg twice daily (BID), respectively.’.

UR - http://www.scopus.com/inward/record.url?scp=85173165147&partnerID=8YFLogxK

U2 - 10.1038/s41408-023-00926-3

DO - 10.1038/s41408-023-00926-3

M3 - Comment / Debate

C2 - 37783709

AN - SCOPUS:85173165147

SN - 2044-5385

VL - 13

SP - 154

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 1

ER -

Correction: Zanubrutinib: past, present, and future

Abstract

Access to Document

Other files and links

Research output

Zanubrutinib: past, present, and future

Cite this